Biogen to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Biogen to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Cambridge, MA, - - Biogen Inc. (Nasdaq: BIIB) announced today that Michael McDonnell, Chief Financial Officer, and Priya Singhal, M.D., M.P.H., Head of Development, will participate in a fireside chat during the Morgan Stanley 22nd Annual Global Healthcare Conference. The webcast will be live on Wednesday, September 4, 2024, at 10:00 a.m. ET. To access the live webcast, please visit the Investors section of Biogen's website at investors.biogen.com. An archived version of the webcast will be available for at least 30 days following the presentation.
马萨诸塞州剑桥市-渤健公司(Nasdaq: BIIB)今天宣布，首席财务官迈克尔·麦克唐纳和开发负责人Priya Singhal将在摩根士丹利第22届全球医疗保健大会上举行炉边聊天。网络广播将于2024年9月4日上午10:00在ET上直播。要访问现场网络广播，请访问Biogen网站的投资者部分，网址为investors.biogen.com。演示后将提供至少30天的归档版本。
About Biogen
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patient's lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.
关于渤健公司
渤健公司成立于1978年，是一家领先的生物技术公司，开展创新科学，推出新药品，改变患者的生命，并为股东和我们的社区创造价值。我们深刻了解人类生物学，并利用不同的模式来推进首创治疗或疗法，提供优越的治疗结果。我们的方法是冒着大胆的风险，平衡回报，实现长期增长。
We routinely post information that may be important to investors on our website at . Follow us on social media - Facebook, LinkedIn, X, YouTube.
我们定期在网站上发布可能对投资者重要的信息。请关注我们在社交媒体上的动态- Facebook，LinkedIn，X，YouTube。